share_log

Avenue Therapeutics | EFFECT: Others

SEC ·  May 13 06:04
Summary by Moomoo AI
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC). The notice of effectiveness, which is a significant step for the company, was issued on May 10, 2024, at 4:00 PM. This form is typically used by companies to register securities for potential future offerings. The filing, under the file number 333-279125, indicates that Avenue Therapeutics has met the SEC's requirements to potentially offer securities to the public.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC). The notice of effectiveness, which is a significant step for the company, was issued on May 10, 2024, at 4:00 PM. This form is typically used by companies to register securities for potential future offerings. The filing, under the file number 333-279125, indicates that Avenue Therapeutics has met the SEC's requirements to potentially offer securities to the public.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more